You are here: All Products  > CFDA Accepts Ascentage's IND Filing for Lead Drug in Hepatitis B

CFDA Accepts Ascentage's IND Filing for Lead Drug in Hepatitis B

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products